๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207

โœ Scribed by Artur Plonowski; Andrew V Schally; Attila Nagy; Kate Groot; Magdalena Krupa; Nora M Navone; Christopher Logothetis


Book ID
117467135
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
118 KB
Volume
176
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Targeted cytotoxic analog of luteinizing
โœ Kopp๏ฟฝn, Miklos; Nagy, Attila; Schally, Andrew V.; Plonowski, Artur; Halmos, G๏ฟฝbo ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 238 KB ๐Ÿ‘ 2 views

## Background: Receptors for luteinizing hormone-releasing hormone (lh-rh) found in prostate cancers might be used for targeting of chemotherapeutic agents. doxorubicin derivative 2-pyrrolinodoxorubicin (an-201) can be linked to carrier analog [d-lys6]lh-rh to form the targeted cytotoxic analog of

Complete regression of MX-1 human breast
โœ Zsuzsanna Kahรกn; Attila Nagy; Andrew V. Schally; Gรกbor Halmos; Josรฉ M. Arencibia ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 126 KB ๐Ÿ‘ 1 views

BACKGROUND. Receptors for luteinizing hormone-releasing hormone (LH-RH) are found in about 50% of human breast carcinomas. A highly potent cytotoxic agent, 2-pyrrolinodoxorubicin (AN-201), was linked to the agonist [D-Lys 6 ]LH-RH to form a cytotoxic LH-RH analog, AN-207, that can be targeted to LH-